{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:46:28Z","timestamp":1793832388213,"version":"4.6.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Ongoing Research Funding program number , King Saud University, Riyadh, Saudi Arabia.","award":["(ORF-2025R341)"],"award-info":[{"award-number":["(ORF-2025R341)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"DOI":"10.1007\/s11011-026-01791-2","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T08:18:49Z","timestamp":1770279529000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Plasma KCC2, NKCC1, and GABA as peripheral biomarkers in autism spectrum disorder: a combined ROC analysis"],"prefix":"10.1007","volume":"41","author":[{"given":"Afaf","family":"El-Ansary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila Y.","family":"Al-Ayadhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan A.","family":"Alfawaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4748-1919","authenticated-orcid":false,"given":"Hayfa","family":"Al-Ghabban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geir","family":"Bj\u00f8rklund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"key":"1791_CR1","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/J.BIOPSYCH.2008.04.030","volume":"64","author":"C Amiet","year":"2008","unstructured":"Amiet C, Gourfinkel-An I, Bouzamondo A et al (2008) Epilepsy in autism is associated with intellectual disability and gender: evidence from a meta-analysis. Biol Psychiatry 64:577\u2013582. https:\/\/doi.org\/10.1016\/J.BIOPSYCH.2008.04.030","journal-title":"Biol Psychiatry"},{"key":"1791_CR2","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1126\/SCIENCE.1240405","volume":"341","author":"MW Antoine","year":"2013","unstructured":"Antoine MW, H\u00fcbner CA, Arezzo JC, H\u00e9bert JM (2013) A causative link between inner ear defects and long-term striatal dysfunction. Science 341:1120\u20131123. https:\/\/doi.org\/10.1126\/SCIENCE.1240405","journal-title":"Science"},{"key":"1791_CR3","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1111\/J.1528-1167.2011.03247.X","volume":"52","author":"G Barmashenko","year":"2011","unstructured":"Barmashenko G, Hefft S, Aertsen A et al (2011) Positive shifts of the GABAA receptor reversal potential due to altered chloride homeostasis is widespread after status epilepticus. Epilepsia 52:1570\u20131578. https:\/\/doi.org\/10.1111\/J.1528-1167.2011.03247.X","journal-title":"Epilepsia"},{"key":"1791_CR4","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/NRN920","volume":"3","author":"Y Ben-Ari","year":"2002","unstructured":"Ben-Ari Y (2002) Excitatory actions of GABA during development: the nature of the nurture. Nat Rev Neurosci 3:728\u2013739. https:\/\/doi.org\/10.1038\/NRN920","journal-title":"Nat Rev Neurosci"},{"key":"1791_CR5","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/J.NEUROSCIENCE.2014.08.001","volume":"279","author":"Y Ben-Ari","year":"2014","unstructured":"Ben-Ari Y (2014) The GABA excitatory\/inhibitory developmental sequence: a personal journey. Neuroscience 279:187\u2013219. https:\/\/doi.org\/10.1016\/J.NEUROSCIENCE.2014.08.001","journal-title":"Neuroscience"},{"key":"1791_CR6","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/NRN3956","volume":"16","author":"Y Ben-Ari","year":"2015","unstructured":"Ben-Ari Y (2015) Is birth a critical period in the pathogenesis of autism spectrum disorders? Nat Rev Neurosci 16:498\u2013505. https:\/\/doi.org\/10.1038\/NRN3956","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"1791_CR7","doi-asserted-by":"publisher","first-page":"N\/A","DOI":"10.20517\/RDODJ.2023.22","volume":"2024","author":"Y Ben-Ari","year":"2024","unstructured":"Ben-Ari Y (2024) Bumetanide to treat autism spectrum disorders: are complex administrative regulations fit to treat heterogeneous disorders? Rare Dis Orphan Drugs J 2024(3):N\/A-N\/A. https:\/\/doi.org\/10.20517\/RDODJ.2023.22","journal-title":"Rare Dis Orphan Drugs J"},{"key":"1791_CR8","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/J.YEBEH.2015.05.032","volume":"47","author":"FMC Besag","year":"2015","unstructured":"Besag FMC (2015) Current controversies in the relationships between autism and epilepsy. Epilepsy Behav 47:143\u2013146. https:\/\/doi.org\/10.1016\/J.YEBEH.2015.05.032","journal-title":"Epilepsy Behav"},{"issue":"1","key":"1791_CR9","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1684\/EPD.2016.0809","volume":"18","author":"F Besag","year":"2016","unstructured":"Besag F, Aldenkamp A, Caplan R et al (2016) Psychiatric and behavioural disorders in children with epilepsy: an ILAE task force report. Epileptic Disord 18(1):S1. https:\/\/doi.org\/10.1684\/EPD.2016.0809","journal-title":"Epileptic Disord"},{"key":"1791_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/J.CELREP.2023.112934","author":"E Byvaltcev","year":"2023","unstructured":"Byvaltcev E, Behbood M, Schleimer JH et al (2023) KCC2 reverse mode helps to clear postsynaptically released potassium at glutamatergic synapses. Cell Rep. https:\/\/doi.org\/10.1016\/J.CELREP.2023.112934","journal-title":"Cell Rep"},{"key":"1791_CR11","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/J.JNEUMETH.2008.04.019","volume":"172","author":"G Curia","year":"2008","unstructured":"Curia G, Longo D, Biagini G et al (2008) The pilocarpine model of temporal lobe epilepsy. J Neurosci Methods 172:143\u2013157. https:\/\/doi.org\/10.1016\/J.JNEUMETH.2008.04.019","journal-title":"J Neurosci Methods"},{"key":"1791_CR12","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/J.SCIB.2021.01.008","volume":"66","author":"Y Dai","year":"2021","unstructured":"Dai Y, Zhang L, Yu J et al (2021) Improved symptoms following bumetanide treatment in children aged 3\u20136 years with autism spectrum disorder: a randomized, double-blind, placebo-controlled trial. Sci Bull 66:1591\u20131598. https:\/\/doi.org\/10.1016\/J.SCIB.2021.01.008","journal-title":"Sci Bull"},{"key":"1791_CR13","doi-asserted-by":"publisher","unstructured":"Deidda G, Bozarth IF, Cancedda L (2014) Modulation of GABAergic transmission in development and neurodevelopmental disorders: investigating physiology and pathology to gain therapeutic perspectives. Front Cell Neurosci 8. https:\/\/doi.org\/10.3389\/FNCEL.2014.00119","DOI":"10.3389\/FNCEL.2014.00119"},{"key":"1791_CR14","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/ANA.21229","volume":"63","author":"VI Dzhala","year":"2008","unstructured":"Dzhala VI, Brumback AC, Staley KJ (2008) Bumetanide enhances phenobarbital efficacy in a neonatal seizure model. Ann Neurol 63:222\u2013235. https:\/\/doi.org\/10.1002\/ANA.21229","journal-title":"Ann Neurol"},{"key":"1791_CR15","doi-asserted-by":"publisher","first-page":"11745","DOI":"10.1523\/JNEUROSCI.1769-10.2010","volume":"30","author":"VI Dzhala","year":"2010","unstructured":"Dzhala VI, Kuchibhotla KV, Glykys JC et al (2010) Progressive NKCC1-dependent neuronal chloride accumulation during neonatal seizures. J Neurosci 30:11745\u201311761. https:\/\/doi.org\/10.1523\/JNEUROSCI.1769-10.2010","journal-title":"J Neurosci"},{"key":"1791_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS20092146","author":"R Fairless","year":"2019","unstructured":"Fairless R, Williams SK, Diem R (2019) Calcium-binding proteins as determinants of central nervous system neuronal vulnerability to disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/IJMS20092146","journal-title":"Int J Mol Sci"},{"key":"1791_CR17","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/J.1528-1167.2009.02279.X","volume":"51","author":"M Fern\u00e1ndez","year":"2010","unstructured":"Fern\u00e1ndez M, Lao-Peregr\u00edn C, Mart\u00edn ED (2010) Flufenamic acid suppresses epileptiform activity in hippocampus by reducing excitatory synaptic transmission and neuronal excitability. Epilepsia 51:384\u2013390. https:\/\/doi.org\/10.1111\/J.1528-1167.2009.02279.X","journal-title":"Epilepsia"},{"key":"1791_CR18","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1002\/AUR.3005","volume":"16","author":"J Fuentes","year":"2023","unstructured":"Fuentes J, Parellada M, Georgoula C et al (2023) Bumetanide oral solution for the treatment of children and adolescents with autism spectrum disorder: results from two randomized phase III studies. Autism Res 16:2021\u20132034. https:\/\/doi.org\/10.1002\/AUR.3005","journal-title":"Autism Res"},{"key":"1791_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/S12888-022-04033-8","author":"L Geertjens","year":"2022","unstructured":"Geertjens L, Cristian G, Haspels E et al (2022) Single-case experimental designs for bumetanide across neurodevelopmental disorders: BUDDI protocol. BMC Psychiatry. https:\/\/doi.org\/10.1186\/S12888-022-04033-8","journal-title":"BMC Psychiatry"},{"key":"1791_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/S41467-019-12113-9","author":"C G\u00f6ppner","year":"2019","unstructured":"G\u00f6ppner C, Orozco IJ, Hoegg-Beiler MB et al (2019) Pathogenesis of hypertension in a mouse model for human CLCN2 related hyperaldosteronism. Nat Commun. https:\/\/doi.org\/10.1038\/S41467-019-12113-9","journal-title":"Nat Commun"},{"key":"1791_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/J.NBD.2021.105297","author":"P Hampel","year":"2021","unstructured":"Hampel P, Johne M, Gailus B et al (2021) Deletion of the Na-K-2Cl cotransporter NKCC1 results in a more severe epileptic phenotype in the intrahippocampal kainate mouse model of temporal lobe epilepsy. Neurobiol Dis. https:\/\/doi.org\/10.1016\/J.NBD.2021.105297","journal-title":"Neurobiol Dis"},{"key":"1791_CR22","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/s0896-6273(00)80642-x","volume":"21","author":"GL Holmes","year":"1998","unstructured":"Holmes GL, Ben-Ari Y (1998) Seizures in the developing brain: perhaps not so benign after all. Neuron 21:1231\u20134. https:\/\/doi.org\/10.1016\/s0896-6273(00)80642-x","journal-title":"Neuron"},{"key":"1791_CR23","doi-asserted-by":"publisher","first-page":"9866","DOI":"10.1523\/JNEUROSCI.2761-07.2007","volume":"27","author":"G Huberfeld","year":"2007","unstructured":"Huberfeld G, Wittner L, Clemenceau S et al (2007) Perturbed chloride homeostasis and GABAergic signaling in human temporal lobe epilepsy. J Neurosci 27:9866\u20139873. https:\/\/doi.org\/10.1523\/JNEUROSCI.2761-07.2007","journal-title":"J Neurosci"},{"key":"1791_CR24","doi-asserted-by":"publisher","first-page":"11088","DOI":"10.1523\/JNEUROSCI.1234-11.2011","volume":"31","author":"TM Hyde","year":"2011","unstructured":"Hyde TM, Lipska BK, Ali T et al (2011) Expression of GABA signaling molecules KCC2, NKCC1, and GAD1 in cortical development and schizophrenia. J Neurosci 31:11088\u201311095. https:\/\/doi.org\/10.1523\/JNEUROSCI.1234-11.2011","journal-title":"J Neurosci"},{"key":"1791_CR25","doi-asserted-by":"publisher","unstructured":"Jarero-Basulto JJ, Gasca-Mart\u00ednez Y, Rivera-Cervantes MC et al (2018) Interactions between epilepsy and plasticity. Pharmaceuticals (Basel). https:\/\/doi.org\/10.3390\/PH11010017","DOI":"10.3390\/PH11010017"},{"key":"1791_CR26","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/J.0953-816X.2003.03152.X","volume":"19","author":"R Khazipov","year":"2004","unstructured":"Khazipov R, Khalilov I, Tyzio R et al (2004) Developmental changes in GABAergic actions and seizure susceptibility in the rat hippocampus. Eur J Neurosci 19:590\u2013600. https:\/\/doi.org\/10.1111\/J.0953-816X.2003.03152.X","journal-title":"Eur J Neurosci"},{"key":"1791_CR27","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/J.1528-1167.2006.00434.X","volume":"47","author":"HL Kim","year":"2006","unstructured":"Kim HL, Donnelly JH, Tournay AE et al (2006) Absence of seizures despite high prevalence of epileptiform EEG abnormalities in children with autism monitored in a tertiary care center. Epilepsia 47:394\u2013398. https:\/\/doi.org\/10.1111\/J.1528-1167.2006.00434.X","journal-title":"Epilepsia"},{"key":"1791_CR28","doi-asserted-by":"publisher","DOI":"10.1172\/JCI.INSIGHT.136007","author":"PA Kipnis","year":"2020","unstructured":"Kipnis PA, Sullivan BJ, Carter BM, Kadam SD (2020) TrkB agonists prevent postischemic emergence of refractory neonatal seizures in mice. JCI Insight. https:\/\/doi.org\/10.1172\/JCI.INSIGHT.136007","journal-title":"JCI Insight"},{"key":"1791_CR29","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/ANA.24870","volume":"81","author":"N Kourdougli","year":"2017","unstructured":"Kourdougli N, Pellegrino C, Renko JM et al (2017) Depolarizing \u03b3-aminobutyric acid contributes to glutamatergic network rewiring in epilepsy. Ann Neurol 81:251\u2013265. https:\/\/doi.org\/10.1002\/ANA.24870","journal-title":"Ann Neurol"},{"key":"1791_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S1474-4422(09)70304-7","volume":"9","author":"P Kwan","year":"2010","unstructured":"Kwan P, Brodie MJ (2010) Definition of refractory epilepsy: defining the indefinable? Lancet Neurol 9:27\u201329. https:\/\/doi.org\/10.1016\/S1474-4422(09)70304-7","journal-title":"Lancet Neurol"},{"key":"1791_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/TP.2012.124","author":"E Lemonnier","year":"2012","unstructured":"Lemonnier E, Degrez C, Phelep M et al (2012) A randomised controlled trial of bumetanide in the treatment of autism in children. Transl Psychiatry. https:\/\/doi.org\/10.1038\/TP.2012.124","journal-title":"Transl Psychiatry"},{"key":"1791_CR32","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/J.ACRA.2013.03.009","volume":"20","author":"D Liu","year":"2013","unstructured":"Liu D, Zhou XH (2013) Roc analysis in biomarker combination with covariate adjustment. Acad Radiol 20:874\u2013882. https:\/\/doi.org\/10.1016\/J.ACRA.2013.03.009","journal-title":"Acad Radiol"},{"key":"1791_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/FNEUR.2019.01407","author":"R Liu","year":"2020","unstructured":"Liu R, Wang J, Liang S et al (2020) Role of NKCC1 and KCC2 in epilepsy: from expression to function. Front Neurol. https:\/\/doi.org\/10.3389\/FNEUR.2019.01407","journal-title":"Front Neurol"},{"key":"1791_CR34","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1124\/PR.120.019539","volume":"72","author":"W L\u00f6scher","year":"2020","unstructured":"L\u00f6scher W, Potschka H, Sisodiya SM, Vezzani A (2020) Drug resistance in epilepsy: clinical impact, potential mechanisms, and new innovative treatment options. Pharmacol Rev 72:606\u2013638. https:\/\/doi.org\/10.1124\/PR.120.019539","journal-title":"Pharmacol Rev"},{"key":"1791_CR35","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1152\/JN.00970.2011","volume":"108","author":"S Mao","year":"2012","unstructured":"Mao S, Garzon-Muvdi T, Di Fulvio M et al (2012) Molecular and functional expression of cation-chloride cotransporters in dorsal root ganglion neurons during postnatal maturation. J Neurophysiol 108:834\u2013852. https:\/\/doi.org\/10.1152\/JN.00970.2011","journal-title":"J Neurophysiol"},{"key":"1791_CR36","doi-asserted-by":"publisher","unstructured":"McNamara JO, Huang YZ, Leonard AS (2006) Molecular signaling mechanisms underlying epileptogenesis. Sci STKE. https:\/\/doi.org\/10.1126\/STKE.3562006RE12. 2006:","DOI":"10.1126\/STKE.3562006RE12"},{"key":"1791_CR37","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1093\/BRAIN\/AWR041","volume":"134","author":"R Nardou","year":"2011","unstructured":"Nardou R, Yamamoto S, Chazal G et al (2011) Neuronal chloride accumulation and excitatory GABA underlie aggravation of neonatal epileptiform activities by phenobarbital. Brain 134:987\u20131002. https:\/\/doi.org\/10.1093\/BRAIN\/AWR041","journal-title":"Brain"},{"key":"1791_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/BRAINSCI13070976","author":"QY Ooi","year":"2023","unstructured":"Ooi QY, Qin X, Yuan Y et al (2023) Alteration of excitation\/inhibition imbalance in the Hippocampus and Amygdala of drug-resistant epilepsy patients treated with acute vagus nerve stimulation. Brain Sci. https:\/\/doi.org\/10.3390\/BRAINSCI13070976","journal-title":"Brain Sci"},{"key":"1791_CR39","doi-asserted-by":"publisher","first-page":"8465","DOI":"10.1073\/PNAS.0602979103","volume":"103","author":"E Palma","year":"2006","unstructured":"Palma E, Amici M, Sobrero F et al (2006) Anomalous levels of Cl- transporters in the hippocampal subiculum from temporal lobe epilepsy patients make GABA excitatory. Proc Natl Acad Sci U S A 103:8465\u20138468. https:\/\/doi.org\/10.1073\/PNAS.0602979103","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1791_CR40","doi-asserted-by":"publisher","DOI":"10.1542\/PEDS.2013-3787","author":"C Reilly","year":"2014","unstructured":"Reilly C, Atkinson P, Das KB et al (2014) Neurobehavioral comorbidities in children with active epilepsy: a population-based study. Pediatrics. https:\/\/doi.org\/10.1542\/PEDS.2013-3787","journal-title":"Pediatrics"},{"key":"1791_CR41","doi-asserted-by":"publisher","first-page":"3330","DOI":"10.1523\/JNEUROSCI.1574-14.2015","volume":"35","author":"S Robel","year":"2015","unstructured":"Robel S, Buckingham SC, Boni JL et al (2015) Reactive astrogliosis causes the development of spontaneous seizures. J Neurosci 35:3330\u20133345. https:\/\/doi.org\/10.1523\/JNEUROSCI.1574-14.2015","journal-title":"J Neurosci"},{"key":"1791_CR42","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/AUR.2010","volume":"12","author":"E Rubenstein","year":"2019","unstructured":"Rubenstein E, Bishop-Fitzpatrick L (2019) A matter of time: the necessity of temporal language in research on health conditions that present with autism spectrum disorder. Autism Res 12:20\u201325. https:\/\/doi.org\/10.1002\/AUR.2010","journal-title":"Autism Res"},{"key":"1791_CR43","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1034\/J.1601-183X.2003.00037.X","volume":"2","author":"JLR Rubenstein","year":"2003","unstructured":"Rubenstein JLR, Merzenich MM (2003) Model of autism: increased ratio of excitation\/inhibition in key neural systems. Genes Brain Behav 2:255\u2013267. https:\/\/doi.org\/10.1034\/J.1601-183X.2003.00037.X","journal-title":"Genes Brain Behav"},{"key":"1791_CR44","doi-asserted-by":"publisher","DOI":"10.1523\/ENEURO.0337-20.2021","author":"E Rusina","year":"2021","unstructured":"Rusina E, Bernard C, Williamson A (2021) The kainic acid models of temporal lobe epilepsy. eNeuro. https:\/\/doi.org\/10.1523\/ENEURO.0337-20.2021","journal-title":"eNeuro"},{"key":"1791_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/BRAINSCI13020345","author":"ME Santarone","year":"2023","unstructured":"Santarone ME, Zambrano S, Zanotta N et al (2023) EEG features in autism spectrum disorder: a retrospective analysis in a cohort of preschool children. Brain Sci. https:\/\/doi.org\/10.3390\/BRAINSCI13020345","journal-title":"Brain Sci"},{"key":"1791_CR46","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/J.TIPS.2021.09.005","volume":"42","author":"A Savardi","year":"2021","unstructured":"Savardi A, Borgogno M, De Vivo M, Cancedda L (2021) Pharmacological tools to target NKCC1 in brain disorders. Trends Pharmacol Sci 42:1009\u20131034. https:\/\/doi.org\/10.1016\/J.TIPS.2021.09.005","journal-title":"Trends Pharmacol Sci"},{"key":"1791_CR47","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/J.EPLEPSYRES.2016.11.011","volume":"129","author":"B Schmeiser","year":"2017","unstructured":"Schmeiser B, Zentner J, Prinz M et al (2017) Extent of mossy fiber sprouting in patients with mesiotemporal lobe epilepsy correlates with neuronal cell loss and granule cell dispersion. Epilepsy Res 129:51\u201358. https:\/\/doi.org\/10.1016\/J.EPLEPSYRES.2016.11.011","journal-title":"Epilepsy Res"},{"key":"1791_CR48","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/J.CNP.2025.02.008","volume":"10","author":"KM Schubert","year":"2025","unstructured":"Schubert KM, Schmick A, Stattmann M, Galovic M (2025) Prognostic models for seizures and epilepsy after stroke, tumors and traumatic brain injury. Clin Neurophysiol Pract 10:116\u2013128. https:\/\/doi.org\/10.1016\/J.CNP.2025.02.008","journal-title":"Clin Neurophysiol Pract"},{"key":"1791_CR49","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/J.NEUBIOREV.2018.05.001","volume":"90","author":"JT Schulte","year":"2018","unstructured":"Schulte JT, Wierenga CJ, Bruining H (2018) Chloride transporters and GABA polarity in developmental, neurological and psychiatric conditions. Neurosci Biobehav Rev 90:260\u2013271. https:\/\/doi.org\/10.1016\/J.NEUBIOREV.2018.05.001","journal-title":"Neurosci Biobehav Rev"},{"key":"1791_CR50","doi-asserted-by":"publisher","first-page":"536","DOI":"10.2174\/1871527322666230404114911","volume":"23","author":"E Shaker","year":"2024","unstructured":"Shaker E, Agami O El, Salamah A (2024) Bumetanide, a diuretic that can help children with autism spectrum disorder. CNS Neurol Disord Drug Targets 23:536\u2013542. https:\/\/doi.org\/10.2174\/1871527322666230404114911","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"1791_CR51","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/EPI.13270","volume":"57","author":"S Sivakumaran","year":"2016","unstructured":"Sivakumaran S, Maguire J (2016) Bumetanide reduces seizure progression and the development of pharmacoresistant status epilepticus. Epilepsia 57:222\u2013232. https:\/\/doi.org\/10.1111\/EPI.13270","journal-title":"Epilepsia"},{"key":"1791_CR52","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/J.1528-1167.2009.02451.X","volume":"1","author":"M Smith","year":"2010","unstructured":"Smith M, Lou (2010) Neuropsychology in epilepsy: children are not small adults. Epilepsia 51 Suppl 1:68\u201369. https:\/\/doi.org\/10.1111\/J.1528-1167.2009.02451.X","journal-title":"Epilepsia 51 Suppl"},{"key":"1791_CR53","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/J.JAAC.2020.07.888","volume":"60","author":"JJ Sprengers","year":"2021","unstructured":"Sprengers JJ, van Andel DM, Zuithoff NPA et al (2021) Bumetanide for core symptoms of autism spectrum disorder (BAMBI): a single center, double-blinded, participant-randomized, placebo-controlled, phase-2 superiority trial. J Am Acad Child Adolesc Psychiatry 60:865\u2013876. https:\/\/doi.org\/10.1016\/J.JAAC.2020.07.888","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"1791_CR54","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/AUR.3086","volume":"17","author":"JJ Sprengers","year":"2024","unstructured":"Sprengers JJ, Geertjens L, Bruining H (2024) Mechanism-based interventions for ASD cannot be implemented using conventional trial designs. Autism Res 17:202\u2013203. https:\/\/doi.org\/10.1002\/AUR.3086","journal-title":"Autism Res"},{"key":"1791_CR55","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0920-1211(97)01025-5","volume":"27","author":"JL Stringer","year":"1997","unstructured":"Stringer JL, Agarwal KS, Dure LS (1997) Is cell death necessary for hippocampal mossy fiber sprouting? Epilepsy Res 27:67\u201376. https:\/\/doi.org\/10.1016\/S0920-1211(97)01025-5","journal-title":"Epilepsy Res"},{"key":"1791_CR56","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1007\/S10803-022-05841-3","volume":"54","author":"DM van Andel","year":"2024","unstructured":"van Andel DM, Sprengers JJ, K\u00f6nigs M et al (2024) Effects of bumetanide on neurocognitive functioning in children with autism spectrum disorder: secondary analysis of a randomized Placebo-Controlled trial. J Autism Dev Disord 54:894\u2013904. https:\/\/doi.org\/10.1007\/S10803-022-05841-3","journal-title":"J Autism Dev Disord"},{"key":"1791_CR57","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/J.YEBEH.2010.01.024","volume":"17","author":"A Vignoli","year":"2010","unstructured":"Vignoli A, Fabio RA, La Briola F et al (2010) Correlations between neurophysiological, behavioral, and cognitive function in Rett syndrome. Epilepsy Behav 17:489\u2013496. https:\/\/doi.org\/10.1016\/J.YEBEH.2010.01.024","journal-title":"Epilepsy Behav"},{"key":"1791_CR58","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/J.TINS.2021.01.004","volume":"44","author":"MA Virtanen","year":"2021","unstructured":"Virtanen MA, Uvarov P, Mavrovic M et al (2021) The multifaceted roles of KCC2 in cortical development. Trends Neurosci 44:378\u2013392. https:\/\/doi.org\/10.1016\/J.TINS.2021.01.004","journal-title":"Trends Neurosci"},{"key":"1791_CR59","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1007\/S00429-016-1292-Z","volume":"222","author":"F Wang","year":"2017","unstructured":"Wang F, Wang X, Shapiro LA et al (2017) NKCC1 up-regulation contributes to early post-traumatic seizures and increased post-traumatic seizure susceptibility. Brain Struct Funct 222:1543\u20131556. https:\/\/doi.org\/10.1007\/S00429-016-1292-Z","journal-title":"Brain Struct Funct"},{"key":"1791_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/FPSYT.2021.751575","author":"T Wang","year":"2021","unstructured":"Wang T, Shan L, Miao C et al (2021) Treatment effect of bumetanide in children with autism spectrum disorder: a systematic review and meta-analysis. Front Psychiatry. https:\/\/doi.org\/10.3389\/FPSYT.2021.751575","journal-title":"Front Psychiatry"},{"key":"1791_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/J.RASD.2024.102363","volume":"114","author":"HL Xiao","year":"2024","unstructured":"Xiao HL, Zhu H, Jing JQ et al (2024) Can bumetanide be a miraculous medicine for autism spectrum disorder: meta-analysis evidence from randomized controlled trials. Res Autism Spectr Disord 114:102363. https:\/\/doi.org\/10.1016\/J.RASD.2024.102363","journal-title":"Res Autism Spectr Disord"},{"key":"1791_CR62","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1113\/JPHYSIOL.2010.193037","volume":"588","author":"HJ Yau","year":"2010","unstructured":"Yau HJ, Baranauskas G, Martina M (2010) Flufenamic acid decreases neuronal excitability through modulation of voltage-gated sodium channel gating. J Physiol 588:3869\u20133882. https:\/\/doi.org\/10.1113\/JPHYSIOL.2010.193037","journal-title":"J Physiol"},{"key":"1791_CR63","doi-asserted-by":"publisher","unstructured":"Zhang L, Huang CC, Dai Y et al (2020) Symptom improvement in children with autism spectrum disorder following bumetanide administration is associated with decreased GABA\/glutamate ratios. https:\/\/doi.org\/10.1038\/S41398-020-0692-2. Transl Psychiatry 10:","DOI":"10.1038\/S41398-020-0692-2"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-01791-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-026-01791-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-01791-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T08:18:50Z","timestamp":1770279530000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-026-01791-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1791"],"URL":"https:\/\/doi.org\/10.1007\/s11011-026-01791-2","relation":{},"ISSN":["1573-7365"],"issn-type":[{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"assertion":[{"value":"26 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This work was approved by the Ethics Committee of the King Saud University King Khalid Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"Written consent was obtained from the parents of each subject, according to the guidelines of the Ethics Committee of the King Saud University King Khalid Hospital.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"29"}}